SynthesisSpinal cord2026
Evaluating the risk of type 2 diabetes mellitus after spinal cord injury: insights from a systematic review and meta-analysis.
Synthesis in Spinal cord, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Passive heat therapy is feasible but does not affect cardiometabolic health outcomes in persons with spinal cord injury - a pilot study.Experimental physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STUDY
designSystematic review and meta-analysis.
objectivesTo assess the risk of type 2 diabetes mellitus (T2DM) in individuals with spinal cord injury (SCI) and explore factors contributing to this variability.
settingThe studies included in this review were conducted across multiple countries, offering a diverse representation of global prevalence.
methodsA systematic search was conducted. A random-effects meta-analysis estimated the pooled prevalence and odds ratio of data extracted from eligible studies. Meta-regression and subgroup analysis were performed to assess the impact of covariates and study variables.
results28 studies were included, with a total of 99,916 individuals. The pooled prevalence of T2DM in the SCI population was 14.2% (95% CI: 10.3-18%). Moreover, a meta-analysis of the odds ratio (OR) demonstrates the pooled random-effects of 2.3 (95% CI: 1.5-3.5). Geographical differences were a key factor, with higher prevalence reported in the USA (18.9%) compared to other regions (8.2%) (p = 0.002). Age was also positively associated with T2DM prevalence (p = 0.007), with a significant rise observed in individuals over 50. Additionally, a significantly higher pooled prevalence of T2DM among the veteran population compared to non-veterans has been revealed (21 and 10.3%, respectively).
conclusionOur findings confirm a significantly greater likelihood of T2DM in SCI individuals and a higher burden of T2DM compared to the general population. The correlation between aging and T2DM prevalence emphasizes the necessity for early screening in older SCI individuals.
Indexed as
Identifiers
41233564What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.